Logo 知识与财富的链接
NLRP3炎性小体与慢性炎症相关疾病的研究进展

NLRP3炎性小体与慢性炎症相关疾病的研究进展

ISSN:1674-3806
2020年第13卷第7期
新进展综述
林凯玲,薛 艳(综述),余惠珍(审校) LIN Kai-ling, XUE Yan, YU Hui-zhen
350001 福州,福建医科大学省立临床医学院老年医学研究室(林凯玲,薛 艳,余惠珍);350028 福州,福建省立医院南院心内科(余惠珍) Key Laboratory of Geriatrics, Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China

炎性小体是先天免疫系统的重要组成部分,其中研究热点为NOD样受体蛋白3(NOD-like receptor protein 3,NLRP3)炎性小体,通过激活相应的信号途径参与多种慢性炎症疾病的发生发展。近年来,NLRP3炎性小体在动脉粥样硬化、非酒精性脂肪性肝病、阿尔茨海默病、慢性阻塞性肺疾病和慢性肾脏病等疾病的发生进程中,发挥着重要作用。该文就炎性小体与慢性炎症相关疾病的研究进展作一综述。

[Abstract] Inflammasomes are important components of the innate immune system, among which NOD-like receptor protein 3(NLRP3) is a research hotspot. NLRP3 is involved in the occurrence and development of various chronic inflammatory diseases by activating the corresponding signaling pathways. Recent researches demonstrate that inflammasome NLRP3 plays a vital role in the pathogenesis of various diseases, such as atherosclerosis(AS), non-alcoholic fatty liver disease(NAFLD), Alzheimer ′s disease(AD), chronic obstructive pulmonary disease(COPD) and chronic renal disease. In this paper, we review the research progress of inflammasomes and chronic inflammatory related diseases.

认领
收 藏
点 赞
认领进度
0 %

发表评论

ISSN:1674-3806
2020年第13卷第7期
新进展综述

用户信息设置